Originally developed in the lab of Phillip Sharp at the Massachusetts Institute of Technology, miRNA sponges are transcripts expressed from strong promoters that contain multiple tandem binding sites to an miRNA of interest.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.